VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Activity

86 hedge funds and large institutions have $4.75M invested in VistaGen Therapeutics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 27 reducing their positions, and 17 closing their positions.

Holders
86
Holders Change
-7
Holders Change %
-7.53%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
27
Closed
17
Calls
$4K
Puts
$2K
Net Calls
+$2K
Net Calls Change
-$401K

Top Buyers

1
BlackRock
1
BlackRock
New York
$1.26M
2
State Street
2
State Street
Massachusetts
$635K
3
Northern Trust
3
Northern Trust
Illinois
$180K
4
GWSG
4
GPS Wealth Strategies Group
Colorado
$25.3K
5
UBS Group
5
UBS Group
Switzerland
$18.3K

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$11K
3
MCM
3
MAI Capital Management
Ohio
$63.6K
4
Millennium Management
4
Millennium Management
New York
$11K
5
CM
5
Caption Management
Oklahoma
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SSG
101
Summit Securities Group
New York
$0 3 -15 -83%
GI
102
Gradient Investments
Minnesota
– – -1 Closed
CSS
103
Cubist Systematic Strategies
Connecticut
– – – –
CM
104
Crestline Management
Texas
– – – –
CFGS
105
Concourse Financial Group Securities
Alabama
– – – –
1 2 3 4
5